Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Clinical Breast Canc...arrow_drop_down
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao
Clinical Breast Cancer
Article . 2012 . Peer-reviewed
License: Elsevier TDM
Data sources: Crossref
versions View all 2 versions
addClaim

Case Report of a Male Primary Breast Carcinoma of Axillary Accessory Mammary Gland

Authors: Yi, Lin; Yuzhou, Wang;

Case Report of a Male Primary Breast Carcinoma of Axillary Accessory Mammary Gland

Abstract

A 65-year-old male patient noticed a mass about 2 cm in diameter in the right axillary region in 2008. He consulted a local dermatologist and the mass was diagnosed as benign. In May 2010, after follow-up of 2 years, the mass began to enlarge at a discernible rate, with the presence of tenderness. There was no history of fever, cough, weight loss, decreased appetite, altered bowel habits, melena, or rectal bleeding. He was transferred to the surgical department of an academic medical center for further treatment. At the initial visit, physical examination revealed an elastic hard, nonmobile mass measuring 5.5 cm, with tenderness to palpation in the right axilla. Part of the skin covering the mass was reddish. There was no significant enlargement of other superficial lymph nodes. Both breasts were normal on palpation. Physical examination was otherwise unremarkable.

Related Organizations
Keywords

Male, Paclitaxel, Radiotherapy, Adenocarcinoma, Combined Modality Therapy, Breast Neoplasms, Male, Tamoxifen, Antineoplastic Combined Chemotherapy Protocols, Axilla, Humans, Anthracyclines, Female, Cyclophosphamide, Aged

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    9
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Top 10%
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Top 10%
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
9
Top 10%
Top 10%
Average
Upload OA version
Are you the author of this publication? Upload your Open Access version to Zenodo!
It’s fast and easy, just two clicks!